...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Erythrocytosis: the HIF pathway in control.
【24h】

Erythrocytosis: the HIF pathway in control.

机译:红细胞增多症:控制中的HIF途径。

获取原文
获取原文并翻译 | 示例

摘要

Organisms living under aerobic conditions need oxygen for the metabolic conversion of nutrition into energy. With the appearance of increasingly complex animals, a specialized transport system (erythrocytes) arose during evolution to provide oxygen to virtually every single cell in the body. Moreover, in case of low environmental partial pressure of oxygen, the number of erythrocytes automatically increases to preserve sustained oxygen delivery. This process relies predominantly on the cytokine erythropoietin (Epo) and its transcription factor hypoxia inducible factor (HIF), whereas the von Hippel-Lindau (VHL) ubiquitin ligase as well as the oxygen-sensitive prolyl hydroxylases (PHDs) represent essential regulators of this oxygen-sensing system. Deregulation of particular members of this pathway (eg, PHD2, HIF2α, VHL) lead to disorders in blood homeostasis as a result of insufficient (anemia) or excessive (erythrocytosis) red blood cell production.
机译:生活在有氧条件下的生物需要氧气才能将营养代谢转化为能量。随着越来越复杂的动物的出现,在进化过程中出现了专门的运输系统(红细胞),为体内几乎每个细胞提供氧气。此外,在氧气的环境分压低的情况下,红细胞的数量会自动增加以保持持续的氧气输送。此过程主要依赖于细胞因子促红细胞生成素(Epo)及其转录因子低氧诱导因子(HIF),而von Hippel-Lindau(VHL)泛素连接酶以及对氧敏感的脯氨酰羟化酶(PHD)代表了该过程的重要调节因子氧气感应系统。该途径的特定成员(例如,PHD2,HIF2α,VHL)的失调由于红细胞产生不足(贫血)或过度(红细胞增多)而导致血液稳态的紊乱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号